Maheswari Rajasekaran
Overview
Explore the profile of Maheswari Rajasekaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anthony Jalin A, Rajasekaran M, Prather P, Kwon J, Gajulapati V, Choi Y, et al.
PLoS One
. 2015 Oct;
10(10):e0141600.
PMID: 26517721
Growing evidence suggests that therapeutic strategies to modulate the post-ischemic inflammatory responses are promising approaches to improve stroke outcome. Although the endocannabinoid system has been emerged as an endogenous therapeutic...
2.
Rajasekaran M, Brents L, Franks L, Moran J, Prather P
Toxicol Appl Pharmacol
. 2013 Mar;
269(2):100-8.
PMID: 23537664
K2 or Spice is an emerging drug of abuse that contains synthetic cannabinoids, including JWH-018 and JWH-073. Recent reports indicate that monohydroxylated metabolites of JWH-018 and JWH-073 retain high affinity...
3.
Seely K, Brents L, Franks L, Rajasekaran M, Zimmerman S, Fantegrossi W, et al.
Neuropharmacology
. 2012 Jul;
63(5):905-15.
PMID: 22771770
Mu-opioid and CB1-cannabinoid agonists produce analgesia; however, adverse effects limit use of drugs in both classes. Additive or synergistic effects resulting from concurrent administration of low doses of mu- and...
4.
Kolomeichuk S, Bene A, Upreti M, Dennis R, Lyle C, Rajasekaran M, et al.
Mol Pharmacol
. 2007 Dec;
73(1):128-36.
PMID: 18094076
Vinblastine treatment in all cell lines examined causes a robust increase in c-Jun protein expression and phosphorylation and a corresponding increase in activator protein-1 (AP-1) transcriptional activity. We show in...